Barclays’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$618K Sell
29,098
-288,884
-91% -$5.78M ﹤0.01% 3062
2025
Q4
$5.19M Sell
317,982
-187,409
-37% -$2.83M ﹤0.01% 2194
2025
Q3
$5.91M Sell
505,391
-471,597
-48% -$6.15M ﹤0.01% 2064
2025
Q2
$11.3M Buy
976,988
+191,158
+24% +$1.74M ﹤0.01% 1489
2025
Q1
$6.86M Sell
785,830
-5,127
-0.6% -$64.6K ﹤0.01% 1671
2024
Q4
$11.4M Buy
790,957
+188,421
+31% +$2.97M 0.01% 1479
2024
Q3
$13.6M Buy
602,536
+80,579
+15% +$1.67M 0.01% 1269
2024
Q2
$10.2M Buy
521,957
+464,221
+804% +$12.2M ﹤0.01% 1187
2024
Q1
$2.17M Sell
57,736
-208,562
-78% -$9.16M ﹤0.01% 2491
2023
Q4
$14.9M Buy
266,298
+244,099
+1,100% +$10.6M 0.01% 1227
2023
Q3
$916K Buy
22,199
+584
+3% +$30.4K ﹤0.01% 2389
2023
Q2
$1.21M Buy
21,615
+9,970
+86% +$540K ﹤0.01% 2187
2023
Q1
$650K Sell
11,645
-160,027
-93% -$7.47M ﹤0.01% 3074
2022
Q4
$6.26M Buy
171,672
+145,505
+556% +$4.76M 0.01% 1466
2022
Q3
$745K Buy
26,167
+3,815
+17% +$145K ﹤0.01% 2436
2022
Q2
$1.01M Sell
22,352
-18,061
-45% -$937K ﹤0.01% 2336
2022
Q1
$3.07M Buy
+40,413
New +$3.54M ﹤0.01% 1539

Other funds holding TXG